Livagen
Also known as: AEDR peptide, Ala-Glu-Asp-Arg
Clinical Status
Preclinical — Russian bioregulator research.
Mechanism of Action
A tetrapeptide bioregulator targeting hepatic tissue. Modulates liver cell gene expression, promotes hepatocyte regeneration, supports detoxification enzyme activity, and has chromatin-decondensing properties that reactivate silenced genes.
Dosing Defaults
Dose
10 mg
Frequency
1x daily
Administration
Oral capsule
Timing
Morning
Food
fasted
Duration
10-20 day cycles
Dose range: 5-20 mg daily
Fasted morning dosing supports liver function during peak metabolic activity.
Side Effects
- •Mild GI discomfort
- •Transient fatigue
- •Headache
Contraindications & Warnings
- •Not medical advice
- •Limited Western clinical data
Compare
Compare Livagen with another peptide side-by-side.
Ad
Related Anti-Aging & Longevity Peptides
This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.